Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
TENISK ANALYSE d. 2/12/24 (NFA)
https://www.tradingview.com/x/H7T306vf/https://www.tradingview.com/x/Guu6iHlM/
When we look at the chart, we can clearly see that the price has fallen into the zone around 1.6 kr, where we also find the Fibonacci retracement area. This is an area of significant confluence support, where several technical factors meet.
The interesting thing is that the price has not just fallen directly through the zone. Instead, we see an incipient rounding precisely here in the support. This indicates that sellers are gradually becoming exhausted, while buyers are slowly starting to take control. The rounded formation resembles the previous bottom structure, which typically shows that the market is absorbing the selling pressure.
In addition, the price has moved back to retest the top of the previous Ascending Triangle, which was previously broken upwards. That area now acts as structural support – precisely what the chart shows. At the same time, the Anchored VWAP is just below the support zone, providing an extra layer of support should the price wick a bit further down.
Today's spike up was quickly sold off when we hit a local Golden Pocket on the way up. However, this does not change the fact that the overall market structure shows that buyers are slowly taking more control, as we get this rounded bottom formation.
The price can easily dip a bit deeper towards AVWAP, without destroying the bullish narrative. If the rounding continues, and we start to see higher lows on the lower timeframes, the probability is high that the price will try to push up towards higher levels again.
I myself bought at 1.60 kr with a limit-order, which hit the absolute low (so far).
Should this zone be broken, the next major support is around 1.35 kr, where we find the uptrend-VWAP from the bottom.
Hope it makes sense, and that you can use my posts for something constructive :-)
Regards
Sebastian
Good evening!
If, contrary to my expectations, it turns out that SC's revenue does not increase significantly from January 2026, when MC is released with prescription and subsidy, then Denmark will be the only country in the world that has released MC on prescription where revenue remains unchanged. I think that is quite unlikely, and that is the only reason why I have SC in my portfolio.
Technical analysis 27/11/25 (NFA)
https://www.tradingview.com/x/2NZLWY03/
STENO appears to be building value after the big selloff earlier in the week. The past few days' candles are completely inside the body of Tuesday's large red candle, which shows that the market is currently consolidating and accepting the price in this area. This is a classic sign of balance, where both buyers and sellers temporarily agree on “fair value” before the next major move up or down.
At the same time, the price is directly on top of the support area around 1.60 kr, which I have previously mentioned. That level acted as resistance back in September/October, and is now being tested for the first time as real support. There is a clear historical reaction in the zone, and it is also located around the middle of the previous impulsive upward movement, which often functions as a natural retracement area.
In short: The market is building value in an important support zone. A break above 1.72–1.75 kr could indicate a nascent bullish reversal, while a daily close under 1.55 kr would open for further declines towards the next major level around 1.4-1.5 kr. Currently, the price is trading in the middle of a balance area, and the next break will likely determine the direction.
Have a good day!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset ja analyysit
Uutiset ja lehdistötiedotteet
Analyysit
21 marras 05.41
∙
Lehdistötiedote
BioStock: Stenocare acquires Canngros
21 marras 05.41
∙
Lehdistötiedote
BioStock: Stenocare förvärvar Canngros
19 marras 18.56
∙
Lehdistötiedote
STENOCARE share analyst's comments on the CannGros acquisition
18 marras 11.18
∙
Lehdistötiedote
Analyst Group: Analyst Group Comment on STENOCAREs acquisition of CannGros ApS
18 marras 08.59
∙
Lehdistötiedote
STENOCARE: Correction of total shares issued and total nominal share capital:
17 marras 16.56
∙
Lehdistötiedote
STENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal
17 marras 16.01
∙
Lehdistötiedote
STENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal
24 loka 12.31
∙
Lehdistötiedote
Analyst Group: Equity Research Report on STENOCARE - Transforms to a Profitable Growth Company
22 loka 12.54
∙
Lehdistötiedote
Analyst Group: Analyst Group Comment on STENOCARE’s Q3-report 2025
22 loka 06.00
∙
Lehdistötiedote
STENOCARE: Interim report third quarter 2025
14 loka 11.19
∙
Osakeuutinen
TRADING DIREKT: ALEXANDRA STRÅBERG OM SVENSKA ÅTERHÄMTNING
29 elo 13.10
∙
Lehdistötiedote
Analyst Group: Equity Research Report on STENOCARE - Capitalizes on STENOCARE 3.0
27 elo 19.30
∙
Lehdistötiedote
Trading in STENOCARE shares by closely related party to board member
21 elo 10.50
∙
Lehdistötiedote
Analyst Group: Analyst Group Comment on STENOCARE’s Q2-report 2025
21 elo 06.00
∙
Lehdistötiedote
STENOCARE: Interim report second quarter 2025
15 elo 14.05
∙
Osakeuutinen
TRADING DIREKT: JOHANNA ENGLUNDH OM FONDFLÖDEN, TA MED TOBBE
19 touko 08.02
∙
Lehdistötiedote
Analyst Group: Equity Research Report on STENOCARE - Time to Capitalize on STENOCARE 3.0
15 touko 09.36
∙
Lehdistötiedote
Communiqué from the Annual General Meeting of STENOCARE
8 touko 06.00
∙
Lehdistötiedote
STENOCARE: Interim report first quarter 2025
2 touko 12.35
∙
Lehdistötiedote
Medical Cannabis Made Permanent in Denmark: Major Milestone for Patients and STENOCARE
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Tuotteita joiden kohde-etuutena tämä arvopaperi
Sertifikaatit
2025 Q3 -tulosraportti
27 päivää sitten
Uutiset ja analyysit
Uutiset ja lehdistötiedotteet
Analyysit
21 marras 05.41
∙
Lehdistötiedote
BioStock: Stenocare acquires Canngros
21 marras 05.41
∙
Lehdistötiedote
BioStock: Stenocare förvärvar Canngros
19 marras 18.56
∙
Lehdistötiedote
STENOCARE share analyst's comments on the CannGros acquisition
18 marras 11.18
∙
Lehdistötiedote
Analyst Group: Analyst Group Comment on STENOCAREs acquisition of CannGros ApS
18 marras 08.59
∙
Lehdistötiedote
STENOCARE: Correction of total shares issued and total nominal share capital:
17 marras 16.56
∙
Lehdistötiedote
STENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal
17 marras 16.01
∙
Lehdistötiedote
STENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal
24 loka 12.31
∙
Lehdistötiedote
Analyst Group: Equity Research Report on STENOCARE - Transforms to a Profitable Growth Company
22 loka 12.54
∙
Lehdistötiedote
Analyst Group: Analyst Group Comment on STENOCARE’s Q3-report 2025
22 loka 06.00
∙
Lehdistötiedote
STENOCARE: Interim report third quarter 2025
14 loka 11.19
∙
Osakeuutinen
TRADING DIREKT: ALEXANDRA STRÅBERG OM SVENSKA ÅTERHÄMTNING
29 elo 13.10
∙
Lehdistötiedote
Analyst Group: Equity Research Report on STENOCARE - Capitalizes on STENOCARE 3.0
27 elo 19.30
∙
Lehdistötiedote
Trading in STENOCARE shares by closely related party to board member
21 elo 10.50
∙
Lehdistötiedote
Analyst Group: Analyst Group Comment on STENOCARE’s Q2-report 2025
21 elo 06.00
∙
Lehdistötiedote
STENOCARE: Interim report second quarter 2025
15 elo 14.05
∙
Osakeuutinen
TRADING DIREKT: JOHANNA ENGLUNDH OM FONDFLÖDEN, TA MED TOBBE
19 touko 08.02
∙
Lehdistötiedote
Analyst Group: Equity Research Report on STENOCARE - Time to Capitalize on STENOCARE 3.0
15 touko 09.36
∙
Lehdistötiedote
Communiqué from the Annual General Meeting of STENOCARE
8 touko 06.00
∙
Lehdistötiedote
STENOCARE: Interim report first quarter 2025
2 touko 12.35
∙
Lehdistötiedote
Medical Cannabis Made Permanent in Denmark: Major Milestone for Patients and STENOCARE
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
TENISK ANALYSE d. 2/12/24 (NFA)
https://www.tradingview.com/x/H7T306vf/https://www.tradingview.com/x/Guu6iHlM/
When we look at the chart, we can clearly see that the price has fallen into the zone around 1.6 kr, where we also find the Fibonacci retracement area. This is an area of significant confluence support, where several technical factors meet.
The interesting thing is that the price has not just fallen directly through the zone. Instead, we see an incipient rounding precisely here in the support. This indicates that sellers are gradually becoming exhausted, while buyers are slowly starting to take control. The rounded formation resembles the previous bottom structure, which typically shows that the market is absorbing the selling pressure.
In addition, the price has moved back to retest the top of the previous Ascending Triangle, which was previously broken upwards. That area now acts as structural support – precisely what the chart shows. At the same time, the Anchored VWAP is just below the support zone, providing an extra layer of support should the price wick a bit further down.
Today's spike up was quickly sold off when we hit a local Golden Pocket on the way up. However, this does not change the fact that the overall market structure shows that buyers are slowly taking more control, as we get this rounded bottom formation.
The price can easily dip a bit deeper towards AVWAP, without destroying the bullish narrative. If the rounding continues, and we start to see higher lows on the lower timeframes, the probability is high that the price will try to push up towards higher levels again.
I myself bought at 1.60 kr with a limit-order, which hit the absolute low (so far).
Should this zone be broken, the next major support is around 1.35 kr, where we find the uptrend-VWAP from the bottom.
Hope it makes sense, and that you can use my posts for something constructive :-)
Regards
Sebastian
Good evening!
If, contrary to my expectations, it turns out that SC's revenue does not increase significantly from January 2026, when MC is released with prescription and subsidy, then Denmark will be the only country in the world that has released MC on prescription where revenue remains unchanged. I think that is quite unlikely, and that is the only reason why I have SC in my portfolio.
Technical analysis 27/11/25 (NFA)
https://www.tradingview.com/x/2NZLWY03/
STENO appears to be building value after the big selloff earlier in the week. The past few days' candles are completely inside the body of Tuesday's large red candle, which shows that the market is currently consolidating and accepting the price in this area. This is a classic sign of balance, where both buyers and sellers temporarily agree on “fair value” before the next major move up or down.
At the same time, the price is directly on top of the support area around 1.60 kr, which I have previously mentioned. That level acted as resistance back in September/October, and is now being tested for the first time as real support. There is a clear historical reaction in the zone, and it is also located around the middle of the previous impulsive upward movement, which often functions as a natural retracement area.
In short: The market is building value in an important support zone. A break above 1.72–1.75 kr could indicate a nascent bullish reversal, while a daily close under 1.55 kr would open for further declines towards the next major level around 1.4-1.5 kr. Currently, the price is trading in the middle of a balance area, and the next break will likely determine the direction.
Have a good day!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Denmark
Määrä
Osto
1 200
1,645
Myynti
Määrä
1,645
1 749
Viimeisimmät kaupat
Näytä enemmän
Aika
Hinta
Määrä
Ostaja
Myyjä
1,645
200
-
-
1,645
1 000
-
-
1,65
2 000
-
-
1,625
1 179
-
-
1,685
1 179
-
-
Ylin
1,905
VWAP
1,75
Alin
1,625
VaihtoMäärä
0,7 381 745
VWAP
1,75
Ylin
1,905
Alin
1,625
VaihtoMäärä
0,7 381 745
Tietoa osakekaupankäyntiin liittyvistä riskeistä
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Näytä kaikki
Seuraava tapahtuma
2025 Q4 -tulosraportti
26.2.2026
Menneet tapahtumat
2025 Q3 -tulosraportti
6.11.
2025 Q3 -tulosraportti
22.10.
2025 Q2 -tulosraportti
21.8.
2025 Q1 -tulosraportti
8.5.
2024 Q4 -tulosraportti
27.2.
Datan lähde: Quartr, FactSet
Tuotteita joiden kohde-etuutena tämä arvopaperi
Sertifikaatit
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
TENISK ANALYSE d. 2/12/24 (NFA)
https://www.tradingview.com/x/H7T306vf/https://www.tradingview.com/x/Guu6iHlM/
When we look at the chart, we can clearly see that the price has fallen into the zone around 1.6 kr, where we also find the Fibonacci retracement area. This is an area of significant confluence support, where several technical factors meet.
The interesting thing is that the price has not just fallen directly through the zone. Instead, we see an incipient rounding precisely here in the support. This indicates that sellers are gradually becoming exhausted, while buyers are slowly starting to take control. The rounded formation resembles the previous bottom structure, which typically shows that the market is absorbing the selling pressure.
In addition, the price has moved back to retest the top of the previous Ascending Triangle, which was previously broken upwards. That area now acts as structural support – precisely what the chart shows. At the same time, the Anchored VWAP is just below the support zone, providing an extra layer of support should the price wick a bit further down.
Today's spike up was quickly sold off when we hit a local Golden Pocket on the way up. However, this does not change the fact that the overall market structure shows that buyers are slowly taking more control, as we get this rounded bottom formation.
The price can easily dip a bit deeper towards AVWAP, without destroying the bullish narrative. If the rounding continues, and we start to see higher lows on the lower timeframes, the probability is high that the price will try to push up towards higher levels again.
I myself bought at 1.60 kr with a limit-order, which hit the absolute low (so far).
Should this zone be broken, the next major support is around 1.35 kr, where we find the uptrend-VWAP from the bottom.
Hope it makes sense, and that you can use my posts for something constructive :-)
Regards
Sebastian
Good evening!
If, contrary to my expectations, it turns out that SC's revenue does not increase significantly from January 2026, when MC is released with prescription and subsidy, then Denmark will be the only country in the world that has released MC on prescription where revenue remains unchanged. I think that is quite unlikely, and that is the only reason why I have SC in my portfolio.
Technical analysis 27/11/25 (NFA)
https://www.tradingview.com/x/2NZLWY03/
STENO appears to be building value after the big selloff earlier in the week. The past few days' candles are completely inside the body of Tuesday's large red candle, which shows that the market is currently consolidating and accepting the price in this area. This is a classic sign of balance, where both buyers and sellers temporarily agree on “fair value” before the next major move up or down.
At the same time, the price is directly on top of the support area around 1.60 kr, which I have previously mentioned. That level acted as resistance back in September/October, and is now being tested for the first time as real support. There is a clear historical reaction in the zone, and it is also located around the middle of the previous impulsive upward movement, which often functions as a natural retracement area.
In short: The market is building value in an important support zone. A break above 1.72–1.75 kr could indicate a nascent bullish reversal, while a daily close under 1.55 kr would open for further declines towards the next major level around 1.4-1.5 kr. Currently, the price is trading in the middle of a balance area, and the next break will likely determine the direction.
Have a good day!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Denmark
Määrä
Osto
1 200
1,645
Myynti
Määrä
1,645
1 749
Viimeisimmät kaupat
Näytä enemmän
Aika
Hinta
Määrä
Ostaja
Myyjä
1,645
200
-
-
1,645
1 000
-
-
1,65
2 000
-
-
1,625
1 179
-
-
1,685
1 179
-
-
Ylin
1,905
VWAP
1,75
Alin
1,625
VaihtoMäärä
0,7 381 745
VWAP
1,75
Ylin
1,905
Alin
1,625
VaihtoMäärä
0,7 381 745
Tietoa osakekaupankäyntiin liittyvistä riskeistä
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.